You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

urethral cancer associated with invasive bladder cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

Active, not recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +35 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +7 more
Jan 3, 2023

Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

Completed
  • Urinary Bladder Cancer
  • +4 more
  • Neutrophil to lymphocyte ratio
  • Cairo, Egypt
    Ain Shams university
Jul 15, 2023

Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • +2 more
  • PDD-TURBT with hexaminolevulinate (Hexvix®)
  • Power Led Saphira (TM) from KARL STORZ
  • (no location specified)
Jul 24, 2023

Urine-based Molecular Testing vs Cystoscopy for Surveillance of

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • +2 more
  • CxBladder Monitor
  • Cystoscopy
  • Scottsdale, Arizona
  • +2 more
Nov 14, 2023

High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

Not yet recruiting
  • High-risk Non-muscle Invasive Bladder Cancer
  • (no location specified)
Oct 25, 2023

Non-muscle Invasive Bladder Cancer Trial in Chengdu (RC48-ADC)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • Chengdu, Sichuan, China
    West China Hospital
Aug 10, 2023

Non-muscle-invasive Bladder Cancer Trial (Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • Cystoscopy
  • +2 more
  • (no location specified)
Apr 4, 2023

Urologic Cancer, Urologic Tumors, Bladder Cancer Trial in Boston (Electromagnetic Guided Laparoscopy, Ultrasound)

Not yet recruiting
  • Urologic Cancer
  • +7 more
  • Electromagnetic Guided Laparoscopy
  • Ultrasound
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 8, 2023

Muscle Invasive Bladder Carcinoma Trial in Beijing (RC48-ADC, AK104)

Recruiting
  • Muscle Invasive Bladder Carcinoma
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Oct 6, 2023

Non-muscle Invasive Bladder Cancer (NMIBC) Trial in Rozzano (Hyaluronic Acid (HA) sodium salt and Hydeal-D)

Terminated
  • Non-muscle Invasive Bladder Cancer (NMIBC)
  • Hyaluronic Acid (HA) sodium salt and Hydeal-D
  • Rozzano, Mi, Italy
    Humanitas Research Hospital
Sep 29, 2023

BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder

Recruiting
  • Bladder Cancer
    • Little Rock, Arkansas
    • +2 more
    Aug 6, 2023

    Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
      • (no location specified)
      Apr 11, 2023

      Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

      Recruiting
      • Non Muscle Invasive Bladder Cancer
      • N803 plus Bacillus Calmette-Guerin (BCG)
      • Honolulu, Hawaii
        Island Urology
      Aug 7, 2023

      Analytical Specificity of Bladder EpiCheck Test in Healthy

      Completed
      • Non Muscle Invasive Bladder Cancer
      • Non-Muscle Invasive Bladder Urothelial Carcinoma
      • Bladder EpiCheck
      • San Antonio, Texas
        Urology San Antonio
      Sep 3, 2023

      Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)

      Recruiting
      • Bladder Cancer
      • Pseudomonas aeruginosa
      • Jinan, Shandong, China
        Qilu hospital
      Jul 26, 2023

      Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in

      Completed
      Has Results
      • Distal Urethral Cancer
      • +10 more
      • Gemcitabine hydrochloride
      • +3 more
      • Springfield, Missouri
      • +1 more
      Sep 17, 2020

      Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,

      Active, not recruiting
      • Hydronephrosis
      • +18 more
      • Durvalumab
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 31, 2022

      Predicting Post-cystectomy Outcome in Muscle Invasive Bladder

      Recruiting
      • Bladder Cancer
      • develop and validate a deep learning radiomics model based on preoperative enhanced CT image
      • Chongqing, Chongqing, China
        Department of Urology, The First Affiliated Hospital of Chongqin
      Oct 18, 2023

      Non-muscular Invasive Bladder Cancer Trial in Changsha (BCG for therapeutic use)

      Not yet recruiting
      • Non-muscular Invasive Bladder Cancer
      • BCG for therapeutic use
      • Changsha, China
        Hunan Cancer Hospital
      Oct 20, 2023

      Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

      Not yet recruiting
      • Non-Muscle- Invasive Bladder Cancer
      • Durvalumab
      • BCG
      • (no location specified)
      Jul 5, 2023

      Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle (Best

      Not yet recruiting
      • Muscle Invasive Bladder Carcinoma
      • +2 more
      • Best Practice
      • +6 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Sep 18, 2023

      Bladder Cancer Trial in Tianjin (Cadonilimab)

      Recruiting
      • Bladder Cancer
      • Tianjin, Tianjin, China
        Tianjin Medical University Second Hospital
      Aug 23, 2023

      Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

      Recruiting
      • Urothelial Carcinoma
      • +2 more
        • Recife, Pernambuco, Brazil
        • +6 more
        Jul 11, 2023

        Mood Alterations in Non-Muscle Invasive Bladder Cancer Treated

        Recruiting
        • Non-Muscle Invasive Bladder Cancer
        • Questionnaires
        • +4 more
        • Washington, District of Columbia
          Sibley Memorial Hospital
        Jan 17, 2023

        Uromonitor asBiomarker for Optimization of NMIBC Management by

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
          • (no location specified)
          May 9, 2023